Ed Schuuring

16.1k citations

240 papers · 8.4k indexed · 1 hit paper · h-index 49

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 63
Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 37
Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies 33
Oncology top 0.5%
- Lung Cancer Research Studies 19
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 18
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 64
Epidemiology
- Cervical Cancer and HPV Research 36
Molecular Biology
- Epigenetics and DNA Methylation 21

Co-authors: Philip M. Kluin G. Bea A. Wisman Katja Philippo Daphne de Jong Ate G.J. van der Zee Evert-Jan G. Boerma Gustaaf W. van Imhoff Hanneke C. Kluin‐Nelemans
Cited by: Cancer Research Pathology and Forensic Medicine Otorhinolaryngology
Journals: Genes Chromosomes and Cancer (14 papers)Blood (10 papers)International Journal of Cancer (9 papers)
Partner nations: Netherlands Belgium Germany

In The Last Decade

Ed Schuuring

236 papers receiving 8.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Ed Schuuring

Since Specialization

Citations

This map shows the geographic impact of Ed Schuuring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Schuuring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Schuuring more than expected).

Fields of papers citing papers by Ed Schuuring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Schuuring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Schuuring. The network helps show where Ed Schuuring may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ed Schuuring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ed Schuuring Line = papers co-authored together Ed Schuuring links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients Communications Medicine ·Paul van der Leest,Jier Yang,George O'Dell Frie,Anthonie J. van der Wekken,Jennet Dickinson,L Memmel,Grigory Sidorenkov,Léon C.L.T. van Kempen,T. Jeroen N. Hiltermann,Ed Schuuring	2025	4
2	112P Reporting of molecular test results from cell-free DNA analyses: Expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA workshop Annals of Oncology ·Veronique de Jager,Patrizio Giacomini,Janet A. Fairley,Chester Freed,Simon Patton,Simon A. Joosse,Chanh Cu Le,Felipe Zuluaga,Ellen Heitzer,Ed Schuuring	2024	0
3	Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme Clinical Epigenetics ·S. Abbas,Arkajyoti Bhattacharya,Marieke T. de Boer,Bettien M. van Hemel,Rozanna Mulyani,Karin M. Vermeulen,Geertruida H. de Bock,Ed Schuuring,G. Bea A. Wisman	2023	7
4	Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer Scientific Reports ·Cicih Widianingsih,G. Girbino,Menno Tamminga,Gerton Lunter,Léon C.L.T. van Kempen,Ed Schuuring,T. Jeroen N. Hiltermann,Harry J.M. Groen	2023	3
5	A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice Journal of Molecular Diagnostics ·Darmi Darmi,Ed Schuuring,M. B. Abika Adline Praicy,Paul van der Leest,Maartje J. Geerlings,Jier Yang,Ali Johnston,Theodora C. Linders,Léon C.L.T. van Kempen,Remond J.A. Fijneman,Marjolijn J. L. Ligtenberg,Gerrit A. Meijer,Daan van den Broek,Valesca P. Retèl,Veerle M.H. Coupé	2022	18
6	Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands JCO Precision Oncology ·Jean-Luc Bouyer,Elisabeth M. P. Steeghs,Vincent L. Parrish,Harry J.M. Groen,Eddy Adang,Stefan M. Willems,Katrien Grünberg,Ed Schuuring,Marjolijn J. L. Ligtenberg,Bastiaan B.J. Tops,Veerle M.H. Coupé	2022	22
7	Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors JCO Precision Oncology ·Sabrina Weber,Paul van der Leest,Cicih Widianingsih,Thomas Schlange,Wim Timens,Menno Tamminga,紘毅高島,Ricarda Graf,Tina Moser,水野勉,Marie‐Laure Yaspo,Leon W.M.M. Terstappen,Grigory Sidorenkov,T. Jeroen N. Hiltermann,Michael R. Speicher,Ed Schuuring,Ellen Heitzer,Harry J.M. Groen	2021	45
8	An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients Cancers ·高木信介,Anna A. Rybczynska,慶子北里,Martijn Terpstra,Ali Saber,Gu Jia-Yao,Wim Timens,Ed Schuuring,T. Jeroen N. Hiltermann,Harry J.M. Groen,Anthonie J. van der Wekken,Anke van den Berg,Klaas Kok	2020	9
9	Immune microenvironment composition in non‐small cell lung cancer and its association with survival Clinical & Translational Immunology ·Menno Tamminga,T. Jeroen N. Hiltermann,Ed Schuuring,Wim Timens,Rudolf S.N. Fehrmann,Harry J.M. Groen	2020	126
10	Addition of tumour infiltration depth and extranodal extension improves the prognostic value of the pathological TNM classification for early‐stage oral squamous cell carcinoma Histopathology ·L. Thomas Elliston,Lieuwe J. Melchers,Ed Schuuring,Jan L.N. Roodenburg,György B. Halmos,Boukje A. C. van Dijk,Bert van der Vegt,Max J. H. Witjes	2019	19
11	Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon? Human Mutation ·Cleo Keppens,曾其详,Xuyen Kim Phan,Étienne Rouleau,Marjolijn J. L. Ligtenberg,Ed Schuuring,Elisabeth Dequeker	2019	1
12	Describing the Reportable Range Is Important for Reliable Treatment Decisions Journal of Molecular Diagnostics ·曾其详,Lien Spans,Ed Schuuring,Cleo Keppens,Karen Zwaenepoel,Patrick Pauwels,Jeroen Van Houdt,Elisabeth Dequeker	2018	9
13	Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non–Small Cell Lung Cancer Clinical Cancer Research ·Anthonie J. van der Wekken,P. Hubber,Stephan Neuhäuser,橋本和宣,M F Mastik,Lizza Hendriks,Erik H.F.M. van der Heijden,Monika Looijen-Salamon,Adrianus J. de Langen,Hui Feng,Sietske A. Riemersma,B.E. van den Borne,Ernst‐Jan M. Speel,Anne‐Marie C. Dingemans,T. Jeroen N. Hiltermann,Anke van den Berg,Wim Timens,Ed Schuuring,Harry J.M. Groen	2017	51
14	Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer Clinical Cancer Research ·Maartje Noordhuis,Rudolf S.N. Fehrmann,G. Bea A. Wisman,Esther R. Nijhuis,Jelmer J. van Zanden,Perry D. Moerland,Emiel Ver Loren van Themaat,Haukeline H. Volders,Mirjam Kok,Klaske A. ten Hoor,Harry Hollema,Elisabeth G.E. de Vries,Geertruida H. de Bock,Ate G.J. van der Zee,Ed Schuuring	2011	105
15	CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer Clinical Cancer Research ·Monique C. de Jong,Jimmy Pramana,Jacqueline E. van der Wal,Martin Lacko,Carine J. Peutz‐Kootstra,Jos M. de Jong,Robert P. Takes,Johannes H.A.M. Kaanders,Bernard F. A. M. van der Laan,B. Sireesha,Jeroen C. Jansen,C. Rasch,Marie‐Louise F. van Velthuysen,Reidar Grénman,Frank Hoebers,Ed Schuuring,Michiel W. M. van den Brekel,Adrian C. Begg	2010	135
16	Methylation Markers for CCNA1 and C13ORF18 Are Strongly Associated with High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in Cervical Scrapings Cancer Epidemiology Biomarkers & Prevention ·Nan Yang,Jasper J.H. Eijsink,Ágnes Lendvai,Haukeline H. Volders,Harry Klip,Henk J. Buikema,Bettien M. van Hemel,Ed Schuuring,Ate G.J. van der Zee,G. Bea A. Wisman	2009	55
17	Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer Clinical Cancer Research ·Maartje Noordhuis,Jasper J.H. Eijsink,Klaske A. ten Hoor,B. A. Alibaba,Harry Hollema,Henriëtte J.G. Arts,Elisabeth Pras,John H. Maduro,Anna K.L. Reyners,Geertruida H. de Bock,G. Bea A. Wisman,Ed Schuuring,Ate G.J. van der Zee	2009	92
18	Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome Cancer Research ·Mohammad Obaidul Hoque,Myoung Sook Kim,Kimberly Laskie Ostrow,Junwei Liu,G. Bea A. Wisman,Hannah Lui Park,Maria Luana Poeta,Cármen Jerónimo,Rui Henrique,Ágnes Lendvai,Ed Schuuring,Shahnaz Begum,Eli Rosenbaum,Maté Ongenaert,Keishi Yamashita,Joseph A. Califano,William H. Westra,Ate G.J. van der Zee,Wim Van Criekinge,David Sidransky	2008	115
19	Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma Clinical Cancer Research ·Marije Booman,B. Alenov,Annuska M. Glas,Sietske A. Riemersma,Ekaterina S. Jordanova,Klaas Kok,Andreas Rosenwald,Daphne de Jong,Ed Schuuring,Philip M. Kluin	2006	53
20	A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias Pure Amsterdam UMC ·J Senne,L. Zhu,Shama L. van Zelderen‐Bhola,Toon F.C.M. Smetsers,D. A. A. Yusron,Michel Stul,Hilde Vranckx,Ed Schuuring,Myoung-ki Lee,N. S. Cosmynina	2000	1

About Ed Schuuring

Ed Schuuring is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 240 papers that have together received 8.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (64 papers), Cancer Genomics and Diagnostics (63 papers), Lymphoma Diagnosis and Treatment (37 papers), Cervical Cancer and HPV Research (36 papers), Head and Neck Cancer Studies (33 papers), Epigenetics and DNA Methylation (21 papers), Lung Cancer Research Studies (19 papers) and Chronic Lymphocytic Leukemia Research (18 papers). The work is most often cited by research in Cancer Research (2.2k citations), Pathology and Forensic Medicine (2.6k citations) and Otorhinolaryngology (607 citations). Ed Schuuring has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Philip M. Kluin, G. Bea A. Wisman, Katja Philippo, Daphne de Jong, Ate G.J. van der Zee, Evert-Jan G. Boerma, Gustaaf W. van Imhoff, Hanneke C. Kluin‐Nelemans, Harry J.M. Groen and Geertruida H. de Bock. Their work appears in journals such as Genes Chromosomes and Cancer, Blood, International Journal of Cancer, Cancer Research and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact